Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982-1999

Pediatric Infectious Disease Journal

Volumn 25, Issue 2, 2006, Pages 123-128

  Signorell, Ladina M ^a   Seitz, Dominik ^a   Merkel, Sabina ^a   Berger, Rosemarie ^a   Rudin, Christoph ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Congenital toxoplasmosis; Cord blood screening; Pregnancy; Toxoplasma antibodies

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTOZOON ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD CULTURE; CHILD; CONGENITAL TOXOPLASMOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; SEROPREVALENCE; SWITZERLAND; TOXOPLASMA; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION;

EID: 32144453091     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000195542.43369.96     Document Type: Article

References (26)

1. Bio-Rad Laboratories. Available at: http://www.bio-rad.com.
2. Available at: http://www.bfs.admin.ch/bfs/portal/de/index/themen/ bevoelkerung.html.
3. Desmonts G, Couvreur J. Congenital toxoplasmosis. N Engl J Med. 1974;290:1110-1116.
4. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr. 1989;115:765-769.
5. Mittendorf R, Pryde P, Herschel M, Williams MA. Is routine antenatal toxoplasmosis screening justified in the United States? Statistical considerations in the application of medical screening tests. Clin Obstet Gynecol. 1999;42:163-175.
6. Guerina N, Hsu H, Meissner C, Maguire J, Lynfield R, Stechenberg B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med. 1994;330:1858-1863.
7. Foulon W, Naessens A, Derede M. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol. 1994;11:57-62.
8. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counseling. Lancet. 1999;353:1829-1833.
9. Douche C, Benabdesselam A, Mokhtari F, Le Mer Y. Value of prevention of congenital toxoplasmosis. J Fr Ophtalmol. 1996;19:330-334.
10. Knerer B, Hayde M, Gratz G, Bernaschek G, Strobl W, Pollak A. Direct detection of Toxoplasma gondii with polymerase chain reaction in diagnosis of fetal toxoplasma infection. Wien Klin Wochenschr. 1995;107:137-140.
11. Excler JL, Piens MA, Maisonneuve H, Pujol E, Garin JP. Dépistage de la toxoplasmose acquise chez la femme enceinte et de la toxoplasmose congénitale chez le nouveau-né. Lyon Med. 1985;253:33-38.
12. Desmonts G, Couvreur J. Toxoplasmose congénitale. Ann Pediatr (Paris). 1984;31:805-809.
13. Roux C, Desmonts G, Mulliez N, Gaulier M, Tufferaud G, Marmor D, et al. Toxoplasmosis and pregnancy. Evaluation of 2 years of prevention of congenital toxoplasmosis in the maternity ward of Hôpital Saint-Antoine (1973-1974). J Gynecol Obstet Biol Reprod (Paris). 1976;5:249-264.
14. Lambotte R, Bassleer J, Beaudouin PH, Senterre J, Lhoist R. Toxoplasmose congénitale: évaluation du bénéfice thérapeutique prénatal. J Gynecol Obstet Biol Reprod (Paris). 1976;5:265-269.
15. Thoumsin H, Senterre J, Lambotte R. Twenty-two years of screening for toxoplasmosis in pregnancy: Liege-Belgium. Scand J Infect Dis. 1992;84(suppl):84-85.
16. Kräubig H. Präventive Behandlung der konnatalen toxoplasmose. In: Kirchhoff H, Kräubig H, eds. Toxoplasmose: Praktische Fragen und Ergebnisse. Stuttgart, Germany: Georgthieme Verlag; 1966.
17. Wallon M, Peyron F, Lebech M, Petersen E, Gilbert R, Dunn D. Prenatal treatment and the risk of congenital toxoplasmosis: preliminary findings from two cohort studies Pediatr Res. 1997;42:400. Abstract.
18. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ. 1999;318:1511-1514.
19. Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev. 2000; (2): CD001684.
20. Pratlong F, Boulot P, Villena I, et al. Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. Br J Obstet Gynaecol. 1996;103:552-557.
21. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 1994;331:695-699.
22. Frenkel JK. Toxoplasmosis. Pediatr Clin North Am. 1985;32:917-932.
23. Jacquier P, Hohlfeld P, Vorkauf H, Zuber P. Epidemiology of toxoplasmosis in Switzerland: national study of seroprevalence monitored in pregnant women 1990-1991. Schweiz Med Wochenschr Suppl. 1995;65:29S-38S.
24. Kind C and Swiss Paediatric Surveillance Unit. Symptomatische konnatale Toxoplasmose: Häufigkeit in der Schweiz 1995-1996 (abstr). Schweiz Med Wochenschr. 1996;126(suppl 87):5S.
25. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol. 1973;57:1-17.
26. Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1996;122:309-324.